PEDMARQSI® (sodium thiosulfate solution for infusion) becomes the first and only treatment authorised in Switzerland for the prevention of cisplatin-induced ototoxicity (hearing loss) in patients aged 1 month to
Hence then, the article about norgine announces swissmedic approval of pedmarqsi for the prevention of cisplatin induced hearing loss in children was published today ( ) and is available on PR Newswire ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.
Read More Details
Finally We wish PressBee provided you with enough information of ( Norgine announces Swissmedic approval of PEDMARQSI® for the prevention of cisplatin induced hearing loss in children )
Also on site :
- Go Inside BTS ‘Tonight Show’ Taping, From Fan Jump-Scares to Jimmy Fallon Angling to Be ‘The 8th Member’
- Lord of the Rings Trilogy Has Many Elements That Are Difficult to Watch in the Modern Day
- Trump& 039;s Disapproval Rating Hits All-Time High, Fox News Poll Shows